Skip to main content
Clinical Trials/DRKS00029221
DRKS00029221
Recruiting
Not Applicable

Tissue- and blood-based marker profiles for treatment response to combination treatment of surface hyperthermia and hypofractionated radiotherapy for locally recurrent breast carcinoma. - HISTOTHERM

niversitätsklinikum Freiburg0 sites40 target enrollmentJune 21, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C50.8
Sponsor
niversitätsklinikum Freiburg
Enrollment
40
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 21, 2022
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with skin metastases or recurrent tumors from
  • breast cancer, for whom neither surgery nor conventional fractionated
  • fractionated radiotherapy is an appropriate or effective option.

Exclusion Criteria

  • Intolerance to local anesthetics, pregnancy, lack of capacity to consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials